Matches in Nanopublications for { ?s ?p "[Our study has implications for miR-375 as a potential target in combination with trastuzumab for treating HER2-positive breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP1002390.RAQ-y3zntoiiDflOgGT-KAEIeMn2k44kTMSK4QFjscaBU130_assertion description "[Our study has implications for miR-375 as a potential target in combination with trastuzumab for treating HER2-positive breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1002390.RAQ-y3zntoiiDflOgGT-KAEIeMn2k44kTMSK4QFjscaBU130_provenance.
- NP1158279.RAnNGRBjP1vUOYyuGBGxLylq8LUBh1au_ezaGXqzGEDBU130_assertion description "[Our study has implications for miR-375 as a potential target in combination with trastuzumab for treating HER2-positive breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158279.RAnNGRBjP1vUOYyuGBGxLylq8LUBh1au_ezaGXqzGEDBU130_provenance.
- NP1158280.RAj-7hwXKJqifXoscgBVbPAHHqLkmCr4ZOnQ_fPO6vbrM130_assertion description "[Our study has implications for miR-375 as a potential target in combination with trastuzumab for treating HER2-positive breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158280.RAj-7hwXKJqifXoscgBVbPAHHqLkmCr4ZOnQ_fPO6vbrM130_provenance.